Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Clinical cancer research, 2021-04, Vol.27 (8), p.2179-2189 [Peer Reviewed Journal]2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-3909 ;PMID: 33504555Full text available |
|
2 |
Material Type: Article
|
Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction moduleNature communications, 2016-07, Vol.7 (1), p.12277-9, Article 12277 [Peer Reviewed Journal]Copyright Nature Publishing Group Jul 2016 ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms12277 ;PMID: 27447450Full text available |
|
3 |
Material Type: Article
|
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosusAnnals of the rheumatic diseases, 2016-07, Vol.75 (7), p.1407-1415 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2015-207776 ;PMID: 26324847 ;CODEN: ARDIAOFull text available |
|
4 |
Material Type: Article
|
Human resistin protects against endotoxic shock by blocking LPS–TLR4 interactionProceedings of the National Academy of Sciences - PNAS, 2017-11, Vol.114 (48), p.E10399-E10408 [Peer Reviewed Journal]Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Nov 28, 2017 ;2017 ;ISSN: 0027-8424 ;ISSN: 1091-6490 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1716015114 ;PMID: 29133417Full text available |
|
5 |
Material Type: Article
|
Asprosin, a Fasting-Induced Glucogenic Protein HormoneCell, 2016-04, Vol.165 (3), p.566-579 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.02.063 ;PMID: 27087445Full text available |
|
6 |
Material Type: Article
|
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancerJournal of clinical oncology, 2015-01, Vol.33 (1), p.74-82 [Peer Reviewed Journal]2014 by American Society of Clinical Oncology. ;2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.57.3329 ;PMID: 25403209Full text available |
|
7 |
Material Type: Article
|
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trialThe lancet oncology, 2012-10, Vol.13 (10), p.1045-1054 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(12)70346-7 ;PMID: 22954508 ;CODEN: LANCAOFull text available |
|
8 |
Material Type: Article
|
Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery StrategiesClinical microbiology reviews, 2018-01, Vol.31 (1) [Peer Reviewed Journal]Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 0893-8512 ;EISSN: 1098-6618 ;DOI: 10.1128/cmr.00071-17 ;PMID: 29187396Full text available |
|
9 |
Material Type: Article
|
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging studyThe Lancet infectious diseases, 2021-09, Vol.21 (9), p.1257-1270 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00147-X ;PMID: 33887209Full text available |
|
10 |
Material Type: Article
|
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsThe Lancet (British edition), 2010-05, Vol.375 (9727), p.1695-1703 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 15-May 21, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60491-6 ;PMID: 20472172 ;CODEN: LANCAOFull text available |
|
11 |
Material Type: Article
|
Prion-like spreading of pathological α-synuclein in brainBrain (London, England : 1878), 2013-04, Vol.136 (Pt 4), p.1128-1138 [Peer Reviewed Journal]2014 INIST-CNRS ;The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. 2013 ;ISSN: 0006-8950 ;EISSN: 1460-2156 ;DOI: 10.1093/brain/awt037 ;PMID: 23466394Full text available |
|
12 |
Material Type: Article
|
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60494-3 ;PMID: 24907225 ;CODEN: LANCAOFull text available |
|
13 |
Material Type: Article
|
Vascular endothelial growth factor: a neurovascular target in neurological diseasesNature reviews. Neurology, 2016-08, Vol.12 (8), p.439-454 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 2016 ;ISSN: 1759-4758 ;EISSN: 1759-4766 ;DOI: 10.1038/nrneurol.2016.88 ;PMID: 27364743Full text available |
|
14 |
Material Type: Article
|
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518Journal of clinical oncology, 2017-05, Vol.35 (15), p.1695-1703 [Peer Reviewed Journal]2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.4072 ;PMID: 28384065Full text available |
|
15 |
Material Type: Article
|
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary EmbolismCirculation (New York, N.Y.), 2014-01, Vol.129 (4), p.479-486 [Peer Reviewed Journal]2014 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2015 INIST-CNRS ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.113.005544 ;PMID: 24226805 ;CODEN: CIRCAZFull text available |
|
16 |
Material Type: Article
|
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet (British edition), 2014-08, Vol.384 (9941), p.414-426 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60538-9 ;PMID: 24907224 ;CODEN: LANCAOFull text available |
|
17 |
Material Type: Article
|
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended miceScientific reports, 2017-06, Vol.7 (1), p.2811-16, Article 2811 [Peer Reviewed Journal]Copyright Nature Publishing Group Jun 2017 ;info:eu-repo/semantics/openAccess ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-02557-8 ;PMID: 28588307Full text available |
|
18 |
Material Type: Article
|
Resistin, an Adipokine with Potent Proinflammatory PropertiesThe Journal of immunology (1950), 2005-05, Vol.174 (9), p.5789-5795 [Peer Reviewed Journal]ISSN: 0022-1767 ;ISSN: 1550-6606 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.174.9.5789 ;PMID: 15843582Full text available |
|
19 |
Material Type: Article
|
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet (British edition), 2012-06, Vol.379 (9834), p.2352-2363 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 23-Jun 29, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60768-5 ;PMID: 22632908 ;CODEN: LANCAOFull text available |
|
20 |
Material Type: Article
|
FGF23 induces left ventricular hypertrophyThe Journal of clinical investigation, 2011-11, Vol.121 (11), p.4393-4408 [Peer Reviewed Journal]COPYRIGHT 2011 American Society for Clinical Investigation ;COPYRIGHT 2011 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Nov 2011 ;Copyright © 2011, American Society for Clinical Investigation 2011 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI46122 ;PMID: 21985788Full text available |